Impact of upper blepharoplasty, with or without orbicularis oculi muscle removal, on tear film dynamics and dry eye symptoms: A randomized controlled trial

Background. Dry eye disease (DED) is one of the most common complications following refractive surgery.Purpose. Evaluate the efficacy of an osmoprotective eye drop (Optive®) for the management of induced DED in refractive surgery patients.Design. Double-masked randomised controlled trial.Methods. Twenty-two refractive surgery patients oriented to apply FreshTears (FT;n=13) or Optive (Op;n=9), topically, QID, for 3 months. Eye exams were performed before surgery (T0) and 1-month (T1) and 3-month (T3) follow-up and consisted of tear film osmolarity, Schirmer 1 test, tear film breakup time (TBUT), fluorescein staining, and ocular surface disease index (OSDI) and patient symptoms questionnaires.Main Outcome Measures. Pain and osmolarity.Results. Pain increased significantly for FT at T3 (p<0.05). A reduction in osmolarity was observed at T1 and T3 for Op group (p<0.01) and at T3 for FT group (p<0.05). TBUT showed a decrease between T0 and T1 for FT (p<0.05). Schirmer 1 values increased significantly for Op in T1.Conclusions. Op was superior to FT in regard to pain, osmolarity, TBUT, and Schirmer 1. Osmoprotectant solutes, such as L-carnitine, could attenuate inflammation and secondary DED. Osmoprotective lubricants can be effectively applied for the prevention of refractive surgery-related dry eye symptoms and signs.

Download Full-text

Laser Acupuncture Improves Tear Film Stability in Patients with Dry Eye Disease: A Two-Center Randomized-Controlled Trial

The Journal of Alternative and Complementary Medicine ◽

10.1089/acm.2020.0524 ◽

2021 ◽

Author(s):

Wen-Long Hu ◽

Hun-Ju Yu ◽

Li-Yen Pan ◽

Pei-Chang Wu ◽

Chih-Chin Pan ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Dry Eye ◽

Controlled Trial ◽

Tear Film ◽

Dry Eye Disease ◽

Laser Acupuncture ◽

Eye Disease ◽

Film Stability ◽

Randomized Controlled ◽

Tear Film Stability

Download Full-text

Comparable effects on tear film parameters after femtosecond laser-assisted and conventional cataract surgery

International Ophthalmology ◽

10.1007/s10792-020-01532-z ◽

2020 ◽

Vol 40 (11) ◽

pp. 3097-3104 ◽

Cited By ~ 1

Author(s):

Marc Schargus ◽

Svetlana Ivanova ◽

Gesa Stute ◽

H. Burkhard Dick ◽

Stephanie C. Joachim

Keyword(s):

Femtosecond Laser ◽

Cataract Surgery ◽

Dry Eye ◽

Surgical Techniques ◽

Tear Film ◽

Schirmer Test ◽

Fluorescein Staining ◽

Significant Difference ◽

Eye Symptoms ◽

Dry Eye Symptoms

Abstract Purpose Dry eye symptoms after conventional cataract surgery are a very common problem. Until now, only few data are available on objective tear film parameters in regard to femtosecond laser-assisted cataract surgery (LCS). Aim of this study was therefore to analyze and compare tear film parameter changes between LCS and conventional cataract surgery. Methods A consecutive group of 34 patients, scheduled for cataract surgery, were randomly selected for either LCS or conventional cataract surgery (17 patients/group). Tear film assessments including tear film osmolarity, Schirmer test, MMP-9 analysis via quantitative ELISA, corneal sensitivity, corneal fluorescein staining, and conjunctival fluorescein staining were sequentially evaluated pre- as well as 1 and 3 months postoperatively. Results Both groups showed no significant difference in baseline characteristics. All surgeries were performed without any complications. After 1 and 3 months, there was no statistically significant difference in regard to tear film osmolarity (1 month: p = 0.81, 3 months: p = 1.0), Schirmer test (1 month: p = 0.35, 3 month: p = 0.08), and MMP-9 concentration (1 month: p = 0.36, 3 month: p = 0.28) between the two groups. Conclusions Neither LCS nor conventional cataract surgery affected objective tear film parameters significantly during our 3-month postoperative observation period. Hence, both surgical techniques can be equally used to treat patients without prior dry eye symptoms.

Download Full-text

Photophobia and sensations of dryness in patients with migraine occur independent of baseline tear volume and improve following botulinum toxin A injections

British Journal of Ophthalmology ◽

10.1136/bjophthalmol-2018-312649 ◽

2018 ◽

Vol 103 (8) ◽

pp. 1024-1029 ◽

Cited By ~ 7

Author(s):

Ryan J Diel ◽

Jodi Hwang ◽

Zachary A Kroeger ◽

Roy C Levitt ◽

Constantine D Sarantopoulos ◽

...

Keyword(s):

Botulinum Toxin ◽

Chronic Migraine ◽

Dry Eye ◽

Botulinum Toxin A ◽

Demographic Data ◽

Tear Film ◽

Phenol Red ◽

Toxin A ◽

Eye Symptoms ◽

Dry Eye Symptoms

BackgroundTo evaluate the efficacy of botulinum toxin A (BoNT-A) in reducing photophobia and dry eye symptoms in individuals with chronic migraine. Additionally, we aimed to evaluate tear film volume as a potential contributor to symptoms in these patients.MethodsRetrospective review of 76 patients who received BoNT-A for chronic migraine between 23 August 2017 and 13 December 2017 at the Miami Veterans Affairs Medical Center Neurotoxin Clinic. Demographic data and all comorbidities were queried via chart review. Standardised validated surveys were administered to assess symptoms prior to and after BoNT-A injection. Preinjection tear volumes were obtained using the phenol red thread (PRT) test.ResultsPreinjection migraine, photophobia and dry eye symptom scores were all significantly correlated, p<0.05, and none were associated with preinjection PRT results. After BoNT-A, improvements in migraine, photophobia and dry eye symptoms were also significantly correlated, p<0.05 and similarly did not associate with preinjection PRT results. Photophobia scores significantly improved following BoNT-A, while dry eye symptoms significantly improved in those with severe symptoms at baseline (DEQ-5 score ≥12), p=0.027. In logistic regression analysis of all individuals with dry eye symptoms (DEQ-5 ≥6), individuals with more severe dry eye symptoms were more likely improve, OR 1.27, 95% CI 1.06 to 1.51, p<0.01.ConclusionsBoNT-A significantly improved photophobia in patients being treated for migraine and also improved dry eye symptoms in patients with severe symptoms at baseline, independent of baseline tear film volume. These improvements may be due to modulation of shared trigeminal neural pathways.

Download Full-text

Associations between dry eye symptoms with tear film stability, volume, and osmolarity in a sample of young adults in Kuala Lumpur

Sudanese Journal of Ophthalmology ◽

10.4103/sjopthal.sjopthal_14_18 ◽

2018 ◽

Vol 10 (1) ◽

pp. 32

Author(s):

Bariah Mohd-Ali ◽

MohamadHanif Hajar-Maidin ◽

Asmah Ahmad ◽

Zainora Mohammed ◽

Jamaluddin Mohamed

Keyword(s):

Young Adults ◽

Dry Eye ◽

Tear Film ◽

Kuala Lumpur ◽

Film Stability ◽

Tear Film Stability ◽

Eye Symptoms ◽

Dry Eye Symptoms

Download Full-text

Dry eye symptoms align more closely to non-ocular conditions than to tear film parameters

British Journal of Ophthalmology ◽

10.1136/bjophthalmol-2014-306481 ◽

2015 ◽

Vol 99 (8) ◽

pp. 1126-1129 ◽

Cited By ~ 43

Author(s):

Anat Galor ◽

Elizabeth R Felix ◽

William Feuer ◽

Nabeel Shalabi ◽

Eden R Martin ◽

...

Keyword(s):

Dry Eye ◽

Tear Film ◽

Eye Symptoms ◽

Dry Eye Symptoms

Download Full-text

Tear Film Functions and Dry Eye Symptoms In Young Patients With Pterygium

Beyoglu Eye Journal ◽

10.14744/bej.2019.18853 ◽

2019 ◽

Author(s):

Erkut Küçük

Keyword(s):

Dry Eye ◽

Young Patients ◽

Tear Film ◽

Eye Symptoms ◽

Dry Eye Symptoms

Download Full-text

Effectiveness of eye-light therapy in improving dry eye symptoms

Indian Journal of Clinical and Experimental Ophthalmology ◽

10.18231/j.ijceo.2021.101 ◽

2021 ◽

Vol 7 (3) ◽

pp. 509-514

Author(s):

Onkar H Pirdankar ◽

Vaishal P Kenia ◽

Merlin Saldanha ◽

Raj V Kenia

Keyword(s):

Layer Thickness ◽

Dry Eye ◽

Environmental Changes ◽

Tear Film ◽

Light Therapy ◽

Lipid Layer ◽

Eye Symptoms ◽

Upper Lid ◽

Post Therapy ◽

Dry Eye Symptoms

: We aimed to examine the effectiveness of eye-light therapy in improving the dry eye symptoms.: The retrospective case series where patients who underwent eye-light therapy between March 2019 to May 2020 were analyzed. Twenty patients aged ≥18 years with dry eyes were included. Patients with ocular infections, complications, contact lens users and missing data were excluded. OSDI scores and tear parameters such as noninvasive break up time (NIBUT), lipid layer thickness (LLT), tear meniscus height, meibography of upper and lower lid were evaluated pre and post one month Eye-Light therapy.: Twenty patients with mean±SD age of 43.55±20.53 years and mean spherical equivalent refractive error of 0.69±1.79 diopters were analyzed. OSDI was significantly associated with NBUT (r=-0.50, P = 0.02), lipid layer thickness (r=-0.45, P=0.047) and tear height (r =-0.45, P=0.046). OSDI was positively associated with upper lid meibography (r=0.74, P=<0.001) and lower lid meibography (r=0.45, P=0.045). Post-therapy, reduction in OSDI score post-therapy was present, NBUT was similar, lipid layer thickness and tear height were increased, meibography of upper lid was reduced, and meibography of lower lid did not alter much. Eye-light therapy is effective in reducing dry eye related symptoms with minimal immediate effect on tear film parameters post therapy. Eye-light therapy acts as an adjunct to ameliorate MGD. MGD being a chronic disease requires sustained therapy with environmental changes. Long term evaluation is required to assess the tear film changes and the pattern of efficacy of light therapy.

Download Full-text